Molly A. Vickers

Also affiliated with Bernhard Nocht Institute for Tropical Medicine

MedicineImmunology and MicrobiologySocial Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “The Development of a Novel Nanobody Therapeutic for SARS-CoV-2”.

The Development of a Novel Nanobody Therapeutic for SARS-CoV-2

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.11.17.386532

N/A

0.489DataRank · unranked

25 citations

Joseph P. Gallant, Christopher Massey, Ke Shi, Wanbo Tai, Jian Zheng +14 more

The development of Nanosota-1 as anti-SARS-CoV-2 nanobody drug candidates

eLife(2021)10.7554/elife.64815

N/A

0DataRank · unranked

62 citations

Joseph P. Gallant, Jian Zheng, Christopher Massey, Ke Shi, Wanbo Tai +10 more

Monovalent SARS-CoV-2 mRNA Vaccine Does not Boost Omicron-Specific Immune Response in Diabetic and Control Pediatric Patients

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad366

N/A

0DataRank · unranked

1 citations

Molly A. Vickers, Shannon M Christensen, Daniela Weiskopf, Alessandro Sette, Andrew W. Norris +4 more